Heart Blocks Treatment Devices Market
Heart Blocks Treatment Devices Market Size, Share & Trends Analysis Report by Degree Type (First-Degree Heart Block, Second-Degree Heart Block, and Third-Degree Heart Block), by Product (Transcutaneous Pacing (TCP), Pacemaker, and Mediation), and by End-Users (Hospital Testing, Home Treatment, and Clinics), Forecast Period (2023-2030)
Heart blocks treatment devices market is anticipated to grow at a CAGR of 5.7% during the forecast period (2023-2030). The most frequently utilized medical device used to treat heart blockages is a pacemaker. A pacemaker is a small, battery-operated device implanted beneath the chest skin. The primary driver of the market's expansion globally is the increasing use of heart block treatment devices, that is being supported by improving innovative technologies and an increase in heart blockage prevalence. According to the European Society of Cardiology (ESC) Cardiovascular Disease Statistics, in January 2022, The rates of pacemaker implantation in ESC member countries in 2018–19 ranged from 60 to 1000 per million people. Through the advancement of pacemakers, minimally invasive cardiovascular operations, and an incredibly quick rise in standard of living, the global market for heart block therapy devices is growing.
Segmental Outlook
The global heart blocks treatment devices market is segmented on the degree type, product, and end-users. Based on the degree type, the market is sub-segmented into first-degree heart block, second-degree heart block, third-degree heart block. Based on the product type, the market is sub-segmented into, transcutaneous pacing (TCP), pacemaker, mediation. Further, on the basis of end-users, the market is sub-segmented into hospital testing, home treatment, clinics. Among the end-users, the hospital testing sub-segment is anticipated to hold a considerable share of the market owing to the increase in X-ray and specific dye usage for coronary arteries. The X-ray allows the doctor to determine the location and degree of blockage in coronary arteries. It also demonstrates how efficiently your heart is beating.
The Pacemaker Sub-Segment is Anticipated to Hold a Considerable Share of the Global Heart Blocks Treatment Devices Market
Among the product, the pacemaker sub-segment is expected to hold a considerable share of the global heart blocks treatment devices market. The segmental growth is attributed to increases the uses of person’s heart rate artificially. Pacemakers provide temporary heart pacing in people with symptomatic bradycardia (symptomatic reduced heart rate). Many companies are designing home monitor interfaces that are simple to use for the older patient population, giving this demographic more autonomy and control over their health care. For instance, in May 2023, The latest line of implantable pacemakers from MicroPort® CRM, a cardiac rhythm management company, have been approved by the US Food and Drug Administration (US FDA), along with the VegaTM pacing leads, SmartTouch XTTM tablet-based programmer, and SmartView ConnectTM Bluetooth® home monitor.
Regional Outlook
The global heart blocks treatment devices market is further segmented based on geography including North America (the US, and Canada), Europe (UK, Italy, Spain, Germany, France, and the Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, and Rest of Asia), and the Rest of the World (the Middle East & Africa, and Latin America. Among these, Asia- Pacific is anticipated to hold a prominent share of the market across the globe, owing to the high frequency of heart blockages and a growing demand for therapeutic drugs to effectively treat cardiovascular disorders in the region.
Global Heart Blocks Treatment Devices Market Growth by Region 2023-2030
The North America Region is Expected to Grow at a Significant CAGR in the Global Heart Blocks Treatment Devices Market
Among all regions, the North America regions is anticipated to grow at a considerable CAGR over the forecast period. The regional growth is attributed to the favorable reimbursement rules, a high rate of R&D activities, easy access to modern technology, and improved awareness among patients locally. The heart block treatment devices are expanding at a rapid pace, owing to the presence of a sizable aging population and significant technological improvement in healthcare facilities. According to National Institute of Health (NIH), more than 70% of American populations having pacemakers were aged 65 years old, making up to 3 million Americans who have pacemakers live with them. The severity of the condition is differentiated by the treatment devices for first-degree, second-degree, and third-degree heart blocks. Light-headedness, syncope, angina, shortness of breath, palpitations, and weariness are common symptoms in patients with type II second degree block or third-degree block.
The high prevalence of heart blocks, rising patient demand for therapeutic drugs for effective management of cardiovascular diseases, rising patient awareness, and rising healthcare costs associated with heart-related conditions are the main drivers of growth in the North American region. According to American Health Association, an estimated 50% of those with cardiovascular disease are older than 65, just 12% of those with the condition used wearable technology. Only 14% of elderly heart disease patients adopted wearable technology, despite the fact that 22% of all heart disease risk factors are aged 65 or older.
Market Players Outlook
The major companies serving the heart blocks treatment devices market include Abbott Laboratories, Boston Scientific Corp., Edwards Lifesciences, Johnson & Johnson, Koninklijke Philips N.V., Medtronic, Inc., Lepu Medical Technology Co. Ltd. and others. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers and acquisitions, partnerships, collaborations, funding, and new product launches, to stay competitive in the market. For instance, in September 2022, BIOTRONIK, Inc. collaborated with AliveCor as first in a series of strategic partnerships to use AI-enabled solutions to revolutionize cardiac digital health. Healthcare professionals will have access to clinically pertinent heart rhythm analysis and useful information owing to this pilot partnership as they monitor patients at risk.
The Report Covers
- Market value data analysis of 2022 and forecast to 2030.
- Annualized market revenues ($ million) for each market segment.
- Country-wise analysis of major geographical regions.
- Key companies operating in the global heart blocks treatment devices market. Based on the availability of data, information related to new product launches, and relevant news is also available in the report.
- Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
- Analysis of market-entry and market expansion strategies.
- Competitive strategies by identifying ‘who-stands-where’ in the market.
1. Report Summary
• Current Industry Analysis and Growth Potential Outlook
1.1. Research Methods and Tools
1.2. Market Breakdown
1.2.1. By Segments
1.2.2. By Region
2. Market Overview and Insights
2.1. Scope of the Report
2.2. Analyst Insight & Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendations
2.2.3. Conclusion
3. Competitive Landscape
3.1. Key Company Analysis
3.2. Abbott Laboratories
3.2.1. Overview
3.2.2. Financial Analysis
3.2.3. SWOT Analysis
3.2.4. Recent Developments
3.3. Johnson & Johnson
3.3.1. Overview
3.3.2. Financial Analysis
3.3.3. SWOT Analysis
3.3.4. Recent Developments
3.4. MicroPort Scientific Corp.
3.4.1. Overview
3.4.2. Financial Analysis
3.4.3. SWOT Analysis
3.4.4. Recent Developments
3.5. Key Strategy Analysis
4. Market Segmentation
4.1. Global Heart Blocks Treatment Devices Market by Degree Type
4.1.1. First-Degree Heart Block
4.1.2. Second-Degree Heart Block
4.1.3. Third-Degree Heart Block
4.2. Global Heart Blocks Treatment Devices Market by Product
4.2.1. Transcutaneous Pacing (TCP)
4.2.2. Pacemaker
4.2.3. Mediation
4.3. Global Heart Blocks Treatment Devices Market by End-Users
4.3.1. Hospital Testing
4.3.2. Home treatment
4.3.3. Clinics
5. Regional Analysis
5.1. North America
5.1.1. United States
5.1.2. Canada
5.2. Europe
5.2.1. UK
5.2.2. Germany
5.2.3. Italy
5.2.4. Spain
5.2.5. France
5.2.6. Rest of Europe
5.3. Asia-Pacific
5.3.1. China
5.3.2. India
5.3.3. Japan
5.3.4. South Korea
5.3.5. Rest of Asia-Pacific
5.4. Rest of the World
6. Company Profiles
6.1. BIOTRONIK, Inc.
6.2. Boston Scientific Corp.
6.3. Edwards Lifesciences
6.4. Getinge
6.5. Lepu Medical Technology Beijing Co. Ltd.
6.6. LivaNova, PLC
6.7. McKesson Corp.
6.8. MicroPort Scientific Corp.
6.9. Osypka Medical GmbH
6.10. SCHILLER
6.11. Shree Pacetronix Ltd.
6.12. St. Jude Medical
6.13. Stryker Corp.
6.14. Terumo
6.15. ZOLL Medical Corp.
1. GLOBAL HEART BLOCKS TREATMENT DEVICES MARKET RESEARCH AND ANALYSIS BY DEGREE TYPE, 2022-2030 ($ MILLION)
2. GLOBAL FIRST-DEGREE HEART BLOCK TREATMENT DEVICES MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
3. GLOBAL SECOND-DEGREE HEART BLOCK TREATMENT DEVICES MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
4. GLOBAL THIRD-DEGREE HEART BLOCK TREATMENT DEVICES MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
5. GLOBAL HEART BLOCKS TREATMENT DEVICES MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2022-2030 ($ MILLION)
6. GLOBAL TRANSCUTANEOUS PACING (TCP) DEVICES FOR HEART BLOCKS TREATMENT MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
7. GLOBAL PACEMAKER DEVICES FOR HEART BLOCKS TREATMENT MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
8. GLOBAL MEDIATION DEVICES FOR HEART BLOCKS TREATMENT MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
9. GLOBAL HEART BLOCKS TREATMENT DEVICES MARKET RESEARCH AND ANALYSIS BY END-USERS, 2022-2030 ($ MILLION)
10. GLOBAL HEART BLOCK TREATMENT DEVICES IN HOSPITAL MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
11. GLOBAL HEART BLOCK TREATMENT DEVICES IN HOME TREATMENT MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
12. GLOBAL HEART BLOCK TREATMENT DEVICES IN CLINICS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
13. GLOBAL HEART BLOCKS TREATMENT DEVICES MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
14. NORTH AMERICAN HEART BLOCKS TREATMENT DEVICES MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
15. NORTH AMERICAN HEART BLOCKS TREATMENT DEVICES MARKET RESEARCH AND ANALYSIS BY DEGREE TYPE, 2022-2030 ($ MILLION)
16. NORTH AMERICAN HEART BLOCKS TREATMENT DEVICES MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2022-2030 ($ MILLION)
17. NORTH AMERICAN HEART BLOCKS TREATMENT DEVICES MARKET RESEARCH AND ANALYSIS BY END-USERS, 2022-2030 ($ MILLION)
18. EUROPEAN HEART BLOCKS TREATMENT DEVICES MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
19. EUROPEAN HEART BLOCKS TREATMENT DEVICES MARKET RESEARCH AND ANALYSIS BY DEGREE TYPE, 2022-2030 ($ MILLION)
20. EUROPEAN HEART BLOCKS TREATMENT DEVICES MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2022-2030 ($ MILLION)
21. EUROPEAN HEART BLOCKS TREATMENT DEVICES MARKET RESEARCH AND ANALYSIS BY END-USERS, 2022-2030 ($ MILLION)
22. ASIA- PACIFIC HEART BLOCKS TREATMENT DEVICES MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
23. ASIA- PACIFIC HEART BLOCKS TREATMENT DEVICES MARKET RESEARCH AND ANALYSIS BY DEGREE TYPE, 2022-2030 ($ MILLION)
24. ASIA- PACIFIC HEART BLOCKS TREATMENT DEVICES MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2022-2030 ($ MILLION)
25. ASIA- PACIFIC HEART BLOCKS TREATMENT DEVICES MARKET RESEARCH AND ANALYSIS BY END-USERS, 2022-2030 ($ MILLION)
26. REST OF THE WORLD HEART BLOCKS TREATMENT DEVICES MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
27. REST OF THE WORLD HEART BLOCKS TREATMENT DEVICES MARKET RESEARCH AND ANALYSIS BY DEGREE TYPE, 2022-2030 ($ MILLION)
28. REST OF THE WORLD HEART BLOCKS TREATMENT DEVICES MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2022-2030 ($ MILLION)
29. REST OF THE WORLD HEART BLOCKS TREATMENT DEVICES MARKET RESEARCH AND ANALYSIS BY END-USERS, 2022-2030 ($ MILLION)
1. GLOBAL HEART BLOCKS TREATMENT DEVICES MARKET RESEARCH AND ANALYSIS BY DEGREE TYPE, 2022 VS 2030 (%)
2. GLOBAL FIRST-DEGREE HEART BLOCK TREATMENT DEVICES MARKET RESEARCH AND ANALYSIS BY REGION, 2022 VS 2030 (%)
3. GLOBAL SECOND-DEGREE HEART BLOCK TREATMENT DEVICES MARKET RESEARCH AND ANALYSIS BY REGION, 2022 VS 2030 (%)
4. GLOBAL THIRD-DEGREE HEART BLOCK TREATMENT DEVICES MARKET RESEARCH AND ANALYSIS BY REGION, 2022 VS 2030 (%)
5. GLOBAL HEART BLOCKS TREATMENT DEVICES MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2022 VS 2030 (%)
6. GLOBAL TRANSCUTANEOUS PACING (TCP) DEVICES FOR HEART BLOCKS TREATMENT MARKET RESEARCH AND ANALYSIS BY REGION, 2022 VS 2030 (%)
7. GLOBAL PACEMAKER DEVICES FOR HEART BLOCKS TREATMENT MARKET RESEARCH AND ANALYSIS BY REGION, 2022 VS 2030 (%)
8. GLOBAL MEDIATION DEVICES FOR HEART BLOCKS TREATMENT MARKET RESEARCH AND ANALYSIS BY REGION, 2022 VS 2030 (%)
9. GLOBAL HEART BLOCKS TREATMENT DEVICES MARKET RESEARCH AND ANALYSIS BY END-USERS, 2022 VS 2030 (%)
10. GLOBAL HEART BLOCK TREATMENT DEVICES IN HOSPITAL MARKET RESEARCH AND ANALYSIS BY REGION, 2022 VS 2030 (%)
11. GLOBAL HEART BLOCK TREATMENT DEVICES IN HOME TREATMENT MARKET RESEARCH AND ANALYSIS BY REGION, 2022 VS 2030 (%)
12. GLOBAL HEART BLOCK TREATMENT DEVICES IN CLINICS MARKET RESEARCH AND ANALYSIS BY REGION, 2022 VS 2030 (%)
13. GLOBAL HEART BLOCKS TREATMENT DEVICES MARKET RESEARCH AND ANALYSIS BY REGION, 2022 VS 2030 (%)
14. US HEART BLOCKS TREATMENT DEVICES MARKET SIZE, 2022-2030 ($ MILLION)
15. CANADA HEART BLOCKS TREATMENT DEVICES MARKET SIZE, 2022-2030 ($ MILLION)
16. UK HEART BLOCKS TREATMENT DEVICES MARKET SIZE, 2022-2030 ($ MILLION)
17. FRANCE HEART BLOCKS TREATMENT DEVICES MARKET SIZE, 2022-2030 ($ MILLION)
18. GERMANY HEART BLOCKS TREATMENT DEVICES MARKET SIZE, 2022-2030 ($ MILLION)
19. ITALY HEART BLOCKS TREATMENT DEVICES MARKET SIZE, 2022-2030 ($ MILLION)
20. SPAIN HEART BLOCKS TREATMENT DEVICES MARKET SIZE, 2022-2030 ($ MILLION)
21. REST OF EUROPE HEART BLOCKS TREATMENT DEVICES MARKET SIZE, 2022-2030 ($ MILLION)
22. INDIA HEART BLOCKS TREATMENT DEVICES MARKET SIZE, 2022-2030 ($ MILLION)
23. CHINA HEART BLOCKS TREATMENT DEVICES MARKET SIZE, 2022-2030 ($ MILLION)
24. JAPAN HEART BLOCKS TREATMENT DEVICES MARKET SIZE, 2022-2030 ($ MILLION)
25. SOUTH KOREA HEART BLOCKS TREATMENT DEVICES MARKET SIZE, 2022-2030 ($ MILLION)
26. REST OF ASIA-PACIFIC HEART BLOCKS TREATMENT DEVICES MARKET SIZE, 2022-2030 ($ MILLION)
27. REST OF THE WORLD HEART BLOCKS TREATMENT DEVICES MARKET SIZE, 2022-2030 ($ MILLION)
